We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies... The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc., including minimum market capitalization and liquidity requirements. Show more
IRVINE, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...
WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products...
BlackRock, Inc. (NYSE: BLK) today announced product enhancements to two iShares ETFs as part of an ongoing process to periodically review its product lineup. No action is necessary for investors...
LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock...
CAMBRIDGE, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in...
RALEIGH, N.C., Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to...
Mirati Therapeutics Added To NASDAQ Biotechnology Index PR Newswire SAN DIEGO, Dec. 20, 2018 SAN DIEGO, Dec. 20, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage...
DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development...
BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB). The Board has approved a 3-for-1...
By Anora Mahmudova and Mark DeCambre, MarketWatch S&P 500, Nasdaq Composite on track to mark closing records U.S. stocks swung higher Tuesday, with the Dow Jones Industrial Average making...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.7498 | -0.522581544466 | 143.48 | 145.0751 | 141.695 | 732267 | 143.23098492 | SP |
4 | -1.7198 | -1.1905849775 | 144.45 | 150.565 | 141.695 | 1086456 | 145.83389967 | SP |
12 | -4.6398 | -3.14840198141 | 147.37 | 150.565 | 137.69 | 1153060 | 145.28125915 | SP |
26 | 9.6202 | 7.22725565322 | 133.11 | 150.565 | 123.6 | 1302783 | 138.70494943 | SP |
52 | 21.1802 | 17.4250925545 | 121.55 | 150.565 | 111.83 | 1596766 | 133.06859814 | SP |
156 | -12.2898 | -7.92788027351 | 155.02 | 164.83 | 104.29 | 1863415 | 130.73914311 | SP |
260 | 44.5502 | 45.3760440008 | 98.18 | 177.37 | 92.15 | 2346848 | 135.17203535 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions